Extremely valid point Domum. If I recall from the information provided by the company in deriving its various cost scenarios, the critical data in terms of sensitivity was around the production profile. So while initial flow rates and decline rates were integral to it, the key production factor affecting economics of development and extraction was EUR.
- Forums
- ASX - By Stock
- ASX Today
Extremely valid point Domum. If I recall from the information...
-
- There are more pages in this discussion • 5,106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 88E (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $57.78M |
Open | High | Low | Value | Volume |
0.2¢ | 0.3¢ | 0.2¢ | $8.734K | 3.649M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
183 | 279241904 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 667533307 | 212 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
183 | 279293040 | 0.002 |
299 | 1069431451 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 666533307 | 211 |
0.004 | 290743911 | 107 |
0.005 | 75465047 | 58 |
0.006 | 118476039 | 41 |
0.007 | 24406369 | 26 |
Last trade - 11.45am 16/07/2024 (20 minute delay) ? |
Featured News
88E (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online